{
 "context": "The following article called 'Nevro reports 4Q loss' was published on 2018-02-23. The body of the article is as follows:\n    \nREDWOOD CITY, Calif. (AP) _ Nevro Corp. (NVRO) on Thursday reported a loss of $4.3 million in its fourth quarter.\nThe Redwood City, California-based company said it had a loss of 15 cents per share.\nThe results missed Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 14 cents per share.\nThe maker of an electrical implant that treats leg and back pain posted revenue of $98 million in the period, exceeding Street forecasts. Five analysts surveyed by Zacks expected $97.6 million.\nFor the year, the company reported that its loss widened to $36.7 million, or $1.25 per share. Revenue was reported as $326.7 million.\nNevro expects full-year revenue in the range of $400 million to $410 million.\nNevro shares have risen 15 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $79.41, a drop of 18 percent in the last 12 months.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on NVRO at https://www.zacks.com/ap/NVRO\n\n    The day before the article was published, the stock price of Nevro Corp. was 79.6500015258789 and the day after the article was published, the stock price of Nevro Corp. was ",
 "expected": "84.3499984741211",
 "date": "2018-02-23",
 "ticker": "NVRO",
 "company": "Nevro Corp.",
 "url": "https://www.cnbc.com/2018/02/22/the-associated-press-nevro-reports-4q-loss.html"
}